Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists U. Verdalles; M. Goicoechea; S. García de Vinuesa; E. Torres; A. Hernández; E. Verde; A. Pérez de José; J. Luño;

Hypertensive mediated organ damage evolution in resistant hypertension patients after adding spironolactone Isabel Galceran; Susana Vázquez; Marta Crespo; Julio Pascual; Anna Oliveras;

Renal safety outcomes of spironolactone in patients with resistant hypertension Isabel Galceran; Susana Vázquez; Xavier Durán; Sara Outón; Julio Pascual; Anna Oliveras;